107 related articles for article (PubMed ID: 6977481)
1. Tumour cell-antibody interactions. II. In vitro studies.
Froese G; Berczi I; Israels LG
Immunology; 1982 Feb; 45(2):313-23. PubMed ID: 6977481
[TBL] [Abstract][Full Text] [Related]
2. Tumour cell-antibody interactions. I. In vivo experiments.
Froese G; Berczi I; Israels LG
Immunology; 1982 Feb; 45(2):303-12. PubMed ID: 7061100
[TBL] [Abstract][Full Text] [Related]
3. Novel tumor-specific antigen(s) response observed in a syngeneic lymphoma-bearing host.
Manson LA
Cancer Detect Prev Suppl; 1987; 1():111-20. PubMed ID: 3121177
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic shifts in the L5178Y lymphoma population during progression of the tumor-dormant state in DBA/2 mice.
Trainer DL; Wheelock EF
Cancer Res; 1984 Mar; 44(3):1063-71. PubMed ID: 6607108
[TBL] [Abstract][Full Text] [Related]
5. Identification and immunogenic properties of an 80-kDa surface antigen on a drug-treated tumor variant: relationship to MuLV gp70.
Grohmann U; Ullrich SJ; Mage MG; Appella E; Fioretti MC; Puccetti P; Romani L
Eur J Immunol; 1990 Mar; 20(3):629-36. PubMed ID: 2318253
[TBL] [Abstract][Full Text] [Related]
6. In vivo lysis of L5178Y cells in the establishment of the tumor-dormant state in DBA/2 mice.
Wheelock EF; Weinhold KJ; Ingenito GG; Goldstein LT
J Immunol; 1980 Apr; 124(4):1642-7. PubMed ID: 7365237
[No Abstract] [Full Text] [Related]
7. Polyclonal natural antitumor antibody binding dynamics: preferential release of surface membrane molecules and increased metastasis.
Chow DA; Yuan XY; Tough DF
Invasion Metastasis; 1992; 12(3-4):218-32. PubMed ID: 1294533
[TBL] [Abstract][Full Text] [Related]
8. Characterization of L5178Y cell phenotypes isolated during progression of the tumor-dormant state in DBA2 mice.
Trainer DL; Wheelock EF
Cancer Res; 1984 Jul; 44(7):2897-906. PubMed ID: 6609767
[TBL] [Abstract][Full Text] [Related]
9. Enhanced suppressor macrophage activity associated with termination of the L5178Y cell tumor-dormant state in DBA/2 mice.
Robinson MK; Truitt GA; Okayasu T; Wheelock EF
Cancer Res; 1983 Dec; 43(12 Pt 1):5831-6. PubMed ID: 6227383
[TBL] [Abstract][Full Text] [Related]
10. Morphologic changes in the murine leukemia L5178Y cells treated with antibodies in the absence of complement activity.
Yang TJ; Haddad-Khairallah L; Wachtel A
Exp Mol Pathol; 1981 Aug; 35(1):137-52. PubMed ID: 6166498
[No Abstract] [Full Text] [Related]
11. Antibody-dependent cellular cytotoxicity against drug-induced antigens in L5178Y mouse lymphoma.
Franco P; Veronese F; Levi F; Goldin A; Nicolin A
Br J Cancer; 1982 Aug; 46(2):173-9. PubMed ID: 7150471
[TBL] [Abstract][Full Text] [Related]
12. A role for mast cells and the vasoactive amine serotonin in T cell-dependent immunity to tumors.
Van Loveren H; Den Otter W; Meade R; Terheggen PM; Askenase PW
J Immunol; 1985 Feb; 134(2):1292-9. PubMed ID: 3871209
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of calcium and glucose uptake by murine leukemia L5178Y cells treated with antiserum.
Woodcock-Mitchell J; Yang TJ
J Cell Physiol; 1980 Dec; 105(3):423-9. PubMed ID: 7462334
[TBL] [Abstract][Full Text] [Related]
14. Murine natural antitumor antibodies. III. Interferon treatment of a natural killer-resistant lymphoma: augmentation of natural antibody reactivity and susceptibility to in vivo natural resistance.
Miller VE; Pohajdak B; Greenberg AH
J Natl Cancer Inst; 1983 Aug; 71(2):377-84. PubMed ID: 6576195
[TBL] [Abstract][Full Text] [Related]
15. Elimination of L5178Y cells from tumor-dormant DBA/2 mice by specific active immunotherapy.
Marsili MA; Robinson MK; Truitt GA; Wheelock EF
Cancer Res; 1983 Jan; 43(1):15-21. PubMed ID: 6600159
[TBL] [Abstract][Full Text] [Related]
16. Modulation of thymus-leukemia antigens on mouse leukemia cells induced by IgG, but not IgM, antibody.
Stackpole CW
J Natl Cancer Inst; 1980 Apr; 64(4):917-23. PubMed ID: 6929003
[TBL] [Abstract][Full Text] [Related]
17. Increase of growth of the L5178Y murine lymphoma by means of immunization with radiated L5178Y cells.
Ramos-Damián M; Gómez-Estrada H; Acosta-Ruiz R; Díaz-Esquivel P; Vázquez-Escobosa C
Arch Invest Med (Mex); 1982; 13(1):29-31. PubMed ID: 7065806
[No Abstract] [Full Text] [Related]
18. Cytogenetic analysis of an immunogenic mutant of the L5178Y lymphoma.
Greenberg AH; Manougian J; Ray M; Goldenberg GJ
Acta Cytol; 1980; 24(3):232-6. PubMed ID: 6773281
[TBL] [Abstract][Full Text] [Related]
19. Effects of horse and fetal calf serum on the expression of tumor-associated antigen and tumorigenicity of L5178Y leukemia/lymphoma cells.
Rabinovsky ED; Yang TJ
Leuk Res; 1986; 10(11):1331-40. PubMed ID: 3796035
[TBL] [Abstract][Full Text] [Related]
20. Transplantability and sensitivity to natural killer cells of aclarubicin-resistant murine lymphoma.
Sugimoto Y; Hirakawa Y; Tanaka N; Tahara M; Sato I; Nishimura T; Suzuki H; Tanaka N
Cancer Res; 1986 Nov; 46(11):5646-8. PubMed ID: 3463416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
